Ultragenyx announces new data on UX111 AV gene therapy
Pharmaceutical announced new data demonstrating treatment with UX111 AAV gene therapy led to a statistically significant ...
Ultragenyx reports positive data on gene therapy for rare disease
NOVATO, Calif. - Ultragenyx Pharmaceutical Inc. (NASDAQ: NASDAQ:RARE), a $4.08 billion market cap biotechnology company with 27% revenue growth in the past year, today unveiled new data indicating ...
eLife24 天
Discovery of a Heparan Sulfate Binding Domain in Monkeypox Virus H3 as an Anti-poxviral ...
This work presents important findings regarding the interaction of the monkeypox virus (MPXV) attachment H3 protein with the cellular receptor heparan sulfate and the use of this information to ...
Frontiers2 年
Molecular determinants of the interaction between HSV-1 glycoprotein D and heparan sulfate
All bar graphs and sensorgrams were visualized using GraphPad Prism v. 9.3.1. Three concentrations (50 uM, 25 uM and 12.5 uM) of ninety-six structurally defined, heparan sulfate mimetic ...